Pilots and FAA air traffic control specialists seeking special issuance or special consideration while treated with an SSRI need a neuropsychological evaluation, because depression and the medication itself may affect cognition. This two-page specification, updated 01/29/2020, defines who may test, which records to provide and what the report and score data must contain.
A licensed clinical psychologist who is board certified or board eligible in clinical neuropsychology performs the evaluation and writes the report. The airman or ATCS supplies prior psychiatric and substance-related treatment records and has the complete FAA file sent to the HIMS AME.
Download the current version from the source each time; forms change without notice.
Specifications for Neuropsychological Evaluations for Treatment with SSRI Medications
If your copy of the form is a fillable PDF, upload it once and Vero Documents fills it from the visit note and the chart, ready for you to review and sign. Download, print, or email the finished form, with the patient’s consent.
A form is listed only after its name and number were confirmed on the issuing agency’s or insurer’s own website, or in the form itself. Each entry links to that source. The list was last checked in October 2026. Forms and their requirements change without notice, so check the official page for the current version before you complete one.
Vero is not affiliated with, or endorsed by, the agencies and insurers listed here. Read our editorial policy.
A licensed clinical psychologist who is board certified or board eligible in clinical neuropsychology. Board eligible means having the education, training and experience to sit for certification with the American Board of Clinical Neuropsychology, the American Board of Professional Neuropsychology or the American Board of Pediatric Neuropsychology.
No. Under the FAA's Antidepressant Protocol the authorization decision is made case by case and the AME may not issue. A pilot who meets the criteria and wants to keep taking the medication is referred to a HIMS AME, who assembles the package that includes this evaluation.
The AME defers and notes it on the application. To reapply for regular issuance, the pilot must be off the medication for at least 60 days, with a favorable report from the treating physician showing stable mood and no aeromedically significant side effects.